Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Akso Health Group Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 13.83 | 14.78 | 2.41 | 13.18 | 6 |
| 13.83 | 14.78 | 2.41 | 13.18 | 6 | |
Revenue Growth | -6.40% | 512.09% | -81.68% | 119.69% | - |
Cost of Revenue | 13.84 | 15.06 | 2.29 | 11.91 | 5.39 |
Gross Profit | -0.01 | -0.28 | 0.12 | 1.27 | 0.61 |
Selling, General & Admin | 3.99 | 3.64 | 8.76 | 15.54 | 2.67 |
Operating Expenses | 3.99 | 3.64 | 8.76 | 15.54 | 3.06 |
Operating Income | -4 | -3.92 | -8.64 | -14.27 | -2.46 |
Interest Expense | - | - | - | - | -0.8 |
Currency Exchange Gain (Loss) | 0 | -0 | -0.59 | 1.14 | -0.75 |
Other Non Operating Income (Expenses) | -0 | 0.03 | 0.14 | 0.06 | 0 |
EBT Excluding Unusual Items | -4 | -3.89 | -9.09 | -13.07 | -4.01 |
Impairment of Goodwill | -11.07 | -41.37 | - | - | - |
Asset Writedown | -5.63 | -121.01 | - | - | - |
Pretax Income | -20.7 | -166.27 | -9.09 | -13.07 | -4.01 |
Income Tax Expense | -1.99 | -30.8 | 0.02 | 0.02 | 0.09 |
Earnings From Continuing Operations | -18.72 | -135.47 | -9.12 | -13.08 | -4.1 |
Earnings From Discontinued Operations | - | - | -0.4 | 11.84 | -12.75 |
Net Income to Company | -18.72 | -135.47 | -9.52 | -1.25 | -16.85 |
Minority Interest in Earnings | 0.04 | 0.49 | 0.06 | -0.11 | -0 |
Net Income | -18.67 | -134.98 | -9.46 | -1.36 | -16.85 |
Net Income to Common | -18.67 | -134.98 | -9.46 | -1.36 | -16.85 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 723 | 285 | 47 | 23 | 20 |
Shares Outstanding (Diluted) | 723 | 285 | 47 | 23 | 20 |
Shares Change | 153.50% | 504.37% | 106.30% | 15.07% | 22.06% |
EPS (Basic) | -0.03 | -0.47 | -0.20 | -0.06 | -0.85 |
EPS (Diluted) | -0.03 | -0.48 | -0.22 | -0.08 | -0.85 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -12.79 | 1.02 | 1.35 | -3.25 | -8.63 |
Free Cash Flow Per Share | -0.02 | 0.00 | 0.03 | -0.14 | -0.43 |
Gross Margin | -0.08% | -1.91% | 5.06% | 9.63% | 10.09% |
Operating Margin | -28.92% | -26.55% | -357.78% | -108.23% | -40.94% |
Profit Margin | -134.99% | -913.38% | -391.77% | -10.32% | -280.85% |
Free Cash Flow Margin | -92.49% | 6.92% | 55.97% | -24.68% | -143.81% |
EBITDA | -1.63 | -1.77 | - | -14.25 | -2.44 |
EBITDA Margin | -11.77% | -12.00% | - | -108.09% | -40.63% |
D&A For EBITDA | 2.37 | 2.15 | - | 0.02 | 0.02 |
EBIT | -4 | -3.92 | -8.64 | -14.27 | -2.46 |
EBIT Margin | -28.92% | -26.55% | - | -108.23% | -40.94% |
Revenue as Reported | 13.83 | 14.78 | 2.41 | 13.18 | 6 |
Advertising Expenses | - | - | 0.17 | 0.01 | - |